nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2A—phrenic nerve—lung cancer	0.02	0.419	CbGeAlD
Cyproheptadine—HTR2A—pulmonary artery—lung cancer	0.00725	0.152	CbGeAlD
Cyproheptadine—SLC6A2—respiratory system—lung cancer	0.00203	0.0425	CbGeAlD
Cyproheptadine—DRD2—respiratory system—lung cancer	0.00185	0.0388	CbGeAlD
Cyproheptadine—CHRM1—trachea—lung cancer	0.0017	0.0356	CbGeAlD
Cyproheptadine—HRH1—respiratory system—lung cancer	0.00146	0.0306	CbGeAlD
Cyproheptadine—HRH1—epithelium—lung cancer	0.00122	0.0256	CbGeAlD
Cyproheptadine—HTR2A—respiratory system—lung cancer	0.00122	0.0256	CbGeAlD
Cyproheptadine—CHRM1—lung—lung cancer	0.00122	0.0256	CbGeAlD
Cyproheptadine—HTR2B—lung—lung cancer	0.00121	0.0254	CbGeAlD
Cyproheptadine—HRH1—trachea—lung cancer	0.00108	0.0226	CbGeAlD
Cyproheptadine—SLC6A2—lung—lung cancer	0.00108	0.0226	CbGeAlD
Cyproheptadine—Oedema—Gemcitabine—lung cancer	0.00103	0.00177	CcSEcCtD
Cyproheptadine—Hepatitis—Docetaxel—lung cancer	0.00103	0.00177	CcSEcCtD
Cyproheptadine—Nervousness—Paclitaxel—lung cancer	0.00102	0.00177	CcSEcCtD
Cyproheptadine—Diarrhoea—Topotecan—lung cancer	0.00102	0.00177	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—lung cancer	0.00102	0.00176	CcSEcCtD
Cyproheptadine—HTR2A—epithelium—lung cancer	0.00102	0.0214	CbGeAlD
Cyproheptadine—Hyperhidrosis—Irinotecan—lung cancer	0.00102	0.00176	CcSEcCtD
Cyproheptadine—Dizziness—Vinblastine—lung cancer	0.00102	0.00176	CcSEcCtD
Cyproheptadine—Convulsion—Cisplatin—lung cancer	0.00102	0.00176	CcSEcCtD
Cyproheptadine—Urticaria—Vinorelbine—lung cancer	0.00101	0.00175	CcSEcCtD
Cyproheptadine—Diarrhoea—Erlotinib—lung cancer	0.00101	0.00175	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Gemcitabine—lung cancer	0.001	0.00174	CcSEcCtD
Cyproheptadine—Anorexia—Irinotecan—lung cancer	0.001	0.00174	CcSEcCtD
Cyproheptadine—Vision blurred—Paclitaxel—lung cancer	0.000992	0.00172	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Gemcitabine—lung cancer	0.000992	0.00171	CcSEcCtD
Cyproheptadine—Dizziness—Topotecan—lung cancer	0.000988	0.00171	CcSEcCtD
Cyproheptadine—Tremor—Paclitaxel—lung cancer	0.000986	0.00171	CcSEcCtD
Cyproheptadine—Hypotension—Irinotecan—lung cancer	0.000984	0.0017	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—lung cancer	0.000984	0.0017	CcSEcCtD
Cyproheptadine—DRD2—lung—lung cancer	0.000981	0.0206	CbGeAlD
Cyproheptadine—Anorexia—Gemcitabine—lung cancer	0.000978	0.00169	CcSEcCtD
Cyproheptadine—Vomiting—Vinblastine—lung cancer	0.000977	0.00169	CcSEcCtD
Cyproheptadine—Dizziness—Erlotinib—lung cancer	0.000977	0.00169	CcSEcCtD
Cyproheptadine—Agitation—Paclitaxel—lung cancer	0.000968	0.00167	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—lung cancer	0.000965	0.00167	CcSEcCtD
Cyproheptadine—Headache—Vinblastine—lung cancer	0.000963	0.00166	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—lung cancer	0.000961	0.00166	CcSEcCtD
Cyproheptadine—Hypotension—Gemcitabine—lung cancer	0.000959	0.00166	CcSEcCtD
Cyproheptadine—Oedema—Cisplatin—lung cancer	0.000957	0.00165	CcSEcCtD
Cyproheptadine—Insomnia—Irinotecan—lung cancer	0.000953	0.00165	CcSEcCtD
Cyproheptadine—Vomiting—Topotecan—lung cancer	0.00095	0.00164	CcSEcCtD
Cyproheptadine—Paraesthesia—Irinotecan—lung cancer	0.000946	0.00164	CcSEcCtD
Cyproheptadine—Vertigo—Paclitaxel—lung cancer	0.000946	0.00164	CcSEcCtD
Cyproheptadine—Syncope—Paclitaxel—lung cancer	0.000944	0.00163	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—lung cancer	0.000944	0.00163	CcSEcCtD
Cyproheptadine—Leukopenia—Paclitaxel—lung cancer	0.000942	0.00163	CcSEcCtD
Cyproheptadine—Rash—Topotecan—lung cancer	0.000942	0.00163	CcSEcCtD
Cyproheptadine—Dermatitis—Topotecan—lung cancer	0.000941	0.00163	CcSEcCtD
Cyproheptadine—Vomiting—Erlotinib—lung cancer	0.000939	0.00162	CcSEcCtD
Cyproheptadine—Somnolence—Irinotecan—lung cancer	0.000937	0.00162	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Cisplatin—lung cancer	0.000937	0.00162	CcSEcCtD
Cyproheptadine—Headache—Topotecan—lung cancer	0.000936	0.00162	CcSEcCtD
Cyproheptadine—Tachycardia—Cisplatin—lung cancer	0.000934	0.00161	CcSEcCtD
Cyproheptadine—Rash—Erlotinib—lung cancer	0.000932	0.00161	CcSEcCtD
Cyproheptadine—Dermatitis—Erlotinib—lung cancer	0.000931	0.00161	CcSEcCtD
Cyproheptadine—Palpitations—Paclitaxel—lung cancer	0.00093	0.00161	CcSEcCtD
Cyproheptadine—Convulsion—Etoposide—lung cancer	0.00093	0.00161	CcSEcCtD
Cyproheptadine—Insomnia—Gemcitabine—lung cancer	0.000928	0.0016	CcSEcCtD
Cyproheptadine—Dyspepsia—Irinotecan—lung cancer	0.000927	0.0016	CcSEcCtD
Cyproheptadine—Headache—Erlotinib—lung cancer	0.000926	0.0016	CcSEcCtD
Cyproheptadine—Loss of consciousness—Paclitaxel—lung cancer	0.000925	0.0016	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—lung cancer	0.000925	0.0016	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Cisplatin—lung cancer	0.000925	0.0016	CcSEcCtD
Cyproheptadine—Paraesthesia—Gemcitabine—lung cancer	0.000922	0.00159	CcSEcCtD
Cyproheptadine—Chills—Docetaxel—lung cancer	0.00092	0.00159	CcSEcCtD
Cyproheptadine—Asthenia—Vinorelbine—lung cancer	0.000917	0.00158	CcSEcCtD
Cyproheptadine—Decreased appetite—Irinotecan—lung cancer	0.000916	0.00158	CcSEcCtD
Cyproheptadine—Nausea—Vinblastine—lung cancer	0.000913	0.00158	CcSEcCtD
Cyproheptadine—Somnolence—Gemcitabine—lung cancer	0.000912	0.00158	CcSEcCtD
Cyproheptadine—Convulsion—Paclitaxel—lung cancer	0.000912	0.00158	CcSEcCtD
Cyproheptadine—Anorexia—Cisplatin—lung cancer	0.000912	0.00158	CcSEcCtD
Cyproheptadine—Fatigue—Irinotecan—lung cancer	0.000908	0.00157	CcSEcCtD
Cyproheptadine—Constipation—Irinotecan—lung cancer	0.000901	0.00156	CcSEcCtD
Cyproheptadine—HTR2A—trachea—lung cancer	0.000901	0.0189	CbGeAlD
Cyproheptadine—Hypotension—Cisplatin—lung cancer	0.000894	0.00155	CcSEcCtD
Cyproheptadine—Decreased appetite—Gemcitabine—lung cancer	0.000892	0.00154	CcSEcCtD
Cyproheptadine—Nausea—Topotecan—lung cancer	0.000887	0.00153	CcSEcCtD
Cyproheptadine—Fatigue—Gemcitabine—lung cancer	0.000885	0.00153	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—lung cancer	0.000884	0.00153	CcSEcCtD
Cyproheptadine—Constipation—Gemcitabine—lung cancer	0.000878	0.00152	CcSEcCtD
Cyproheptadine—Nausea—Erlotinib—lung cancer	0.000878	0.00152	CcSEcCtD
Cyproheptadine—Diarrhoea—Vinorelbine—lung cancer	0.000874	0.00151	CcSEcCtD
Cyproheptadine—Feeling abnormal—Irinotecan—lung cancer	0.000868	0.0015	CcSEcCtD
Cyproheptadine—Confusional state—Paclitaxel—lung cancer	0.000866	0.0015	CcSEcCtD
Cyproheptadine—Oedema—Paclitaxel—lung cancer	0.000859	0.00149	CcSEcCtD
Cyproheptadine—Paraesthesia—Cisplatin—lung cancer	0.000859	0.00148	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Etoposide—lung cancer	0.000858	0.00148	CcSEcCtD
Cyproheptadine—Tachycardia—Etoposide—lung cancer	0.000855	0.00148	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—lung cancer	0.000847	0.00146	CcSEcCtD
Cyproheptadine—Feeling abnormal—Gemcitabine—lung cancer	0.000846	0.00146	CcSEcCtD
Cyproheptadine—Shock—Paclitaxel—lung cancer	0.000845	0.00146	CcSEcCtD
Cyproheptadine—Dizziness—Vinorelbine—lung cancer	0.000845	0.00146	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—lung cancer	0.000843	0.00146	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Paclitaxel—lung cancer	0.000841	0.00145	CcSEcCtD
Cyproheptadine—Tachycardia—Paclitaxel—lung cancer	0.000839	0.00145	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—lung cancer	0.000835	0.00144	CcSEcCtD
Cyproheptadine—Decreased appetite—Cisplatin—lung cancer	0.000832	0.00144	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Paclitaxel—lung cancer	0.000831	0.00144	CcSEcCtD
Cyproheptadine—HTR2B—lymph node—lung cancer	0.000829	0.0174	CbGeAlD
Cyproheptadine—Drowsiness—Methotrexate—lung cancer	0.000823	0.00142	CcSEcCtD
Cyproheptadine—Anorexia—Paclitaxel—lung cancer	0.000819	0.00142	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—lung cancer	0.000819	0.00142	CcSEcCtD
Cyproheptadine—Vomiting—Vinorelbine—lung cancer	0.000812	0.0014	CcSEcCtD
Cyproheptadine—Rash—Vinorelbine—lung cancer	0.000805	0.00139	CcSEcCtD
Cyproheptadine—Dermatitis—Vinorelbine—lung cancer	0.000805	0.00139	CcSEcCtD
Cyproheptadine—Hypotension—Paclitaxel—lung cancer	0.000803	0.00139	CcSEcCtD
Cyproheptadine—Headache—Vinorelbine—lung cancer	0.0008	0.00138	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—lung cancer	0.0008	0.00138	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—lung cancer	0.000799	0.00138	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—lung cancer	0.000789	0.00136	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cisplatin—lung cancer	0.000788	0.00136	CcSEcCtD
Cyproheptadine—Paraesthesia—Etoposide—lung cancer	0.000787	0.00136	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—lung cancer	0.000784	0.00136	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—lung cancer	0.000779	0.00135	CcSEcCtD
Cyproheptadine—Insomnia—Paclitaxel—lung cancer	0.000777	0.00134	CcSEcCtD
Cyproheptadine—HRH1—lung—lung cancer	0.000775	0.0163	CbGeAlD
Cyproheptadine—Convulsion—Docetaxel—lung cancer	0.000773	0.00134	CcSEcCtD
Cyproheptadine—Paraesthesia—Paclitaxel—lung cancer	0.000772	0.00133	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—lung cancer	0.000768	0.00133	CcSEcCtD
Cyproheptadine—Protriptyline—ABCB1—lung cancer	0.000767	0.173	CrCbGaD
Cyproheptadine—Somnolence—Paclitaxel—lung cancer	0.000764	0.00132	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—lung cancer	0.000762	0.00132	CcSEcCtD
Cyproheptadine—Nausea—Vinorelbine—lung cancer	0.000759	0.00131	CcSEcCtD
Cyproheptadine—Dyspepsia—Paclitaxel—lung cancer	0.000756	0.00131	CcSEcCtD
Cyproheptadine—Asthenia—Irinotecan—lung cancer	0.000756	0.00131	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—lung cancer	0.000756	0.00131	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—lung cancer	0.000749	0.0013	CcSEcCtD
Cyproheptadine—Decreased appetite—Paclitaxel—lung cancer	0.000747	0.00129	CcSEcCtD
Cyproheptadine—Fatigue—Paclitaxel—lung cancer	0.000741	0.00128	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—lung cancer	0.000739	0.00128	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—lung cancer	0.000738	0.00128	CcSEcCtD
Cyproheptadine—SLC6A2—lymph node—lung cancer	0.000736	0.0154	CbGeAlD
Cyproheptadine—Asthenia—Gemcitabine—lung cancer	0.000736	0.00127	CcSEcCtD
Cyproheptadine—Constipation—Paclitaxel—lung cancer	0.000735	0.00127	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—lung cancer	0.000734	0.00127	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—lung cancer	0.00073	0.00126	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—lung cancer	0.000728	0.00126	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—lung cancer	0.000727	0.00126	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—lung cancer	0.000722	0.00125	CcSEcCtD
Cyproheptadine—Diarrhoea—Irinotecan—lung cancer	0.000721	0.00125	CcSEcCtD
Cyproheptadine—Shock—Docetaxel—lung cancer	0.000717	0.00124	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—lung cancer	0.000713	0.00123	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—lung cancer	0.000713	0.00123	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—lung cancer	0.000711	0.00123	CcSEcCtD
Cyproheptadine—Feeling abnormal—Paclitaxel—lung cancer	0.000708	0.00122	CcSEcCtD
Cyproheptadine—Diarrhoea—Gemcitabine—lung cancer	0.000702	0.00121	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000699	0.00121	CcSEcCtD
Cyproheptadine—Dizziness—Irinotecan—lung cancer	0.000697	0.0012	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—lung cancer	0.000696	0.0012	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—lung cancer	0.000695	0.0012	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—lung cancer	0.000694	0.0012	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—lung cancer	0.000689	0.00119	CcSEcCtD
Cyproheptadine—Asthenia—Cisplatin—lung cancer	0.000686	0.00119	CcSEcCtD
Cyproheptadine—Urticaria—Paclitaxel—lung cancer	0.000683	0.00118	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—lung cancer	0.000681	0.00118	CcSEcCtD
Cyproheptadine—Vomiting—Irinotecan—lung cancer	0.00067	0.00116	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—lung cancer	0.000665	0.00115	CcSEcCtD
Cyproheptadine—Rash—Irinotecan—lung cancer	0.000664	0.00115	CcSEcCtD
Cyproheptadine—Dermatitis—Irinotecan—lung cancer	0.000664	0.00115	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—lung cancer	0.000663	0.00115	CcSEcCtD
Cyproheptadine—Headache—Irinotecan—lung cancer	0.00066	0.00114	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—lung cancer	0.000659	0.00114	CcSEcCtD
Cyproheptadine—Diarrhoea—Cisplatin—lung cancer	0.000655	0.00113	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—lung cancer	0.000654	0.00113	CcSEcCtD
Cyproheptadine—Vomiting—Gemcitabine—lung cancer	0.000653	0.00113	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—lung cancer	0.000647	0.00112	CcSEcCtD
Cyproheptadine—HTR2A—lung—lung cancer	0.000647	0.0136	CbGeAlD
Cyproheptadine—Rash—Gemcitabine—lung cancer	0.000647	0.00112	CcSEcCtD
Cyproheptadine—Dermatitis—Gemcitabine—lung cancer	0.000646	0.00112	CcSEcCtD
Cyproheptadine—Headache—Gemcitabine—lung cancer	0.000643	0.00111	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—lung cancer	0.000641	0.00111	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—lung cancer	0.00064	0.00111	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—lung cancer	0.000633	0.00109	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—lung cancer	0.000629	0.00109	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—lung cancer	0.000628	0.00109	CcSEcCtD
Cyproheptadine—Nausea—Irinotecan—lung cancer	0.000626	0.00108	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—lung cancer	0.000623	0.00108	CcSEcCtD
Cyproheptadine—Asthenia—Paclitaxel—lung cancer	0.000616	0.00107	CcSEcCtD
Cyproheptadine—Nausea—Gemcitabine—lung cancer	0.00061	0.00105	CcSEcCtD
Cyproheptadine—Vomiting—Cisplatin—lung cancer	0.000608	0.00105	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—lung cancer	0.000606	0.00105	CcSEcCtD
Cyproheptadine—Rash—Cisplatin—lung cancer	0.000603	0.00104	CcSEcCtD
Cyproheptadine—Dermatitis—Cisplatin—lung cancer	0.000603	0.00104	CcSEcCtD
Cyproheptadine—Feeling abnormal—Docetaxel—lung cancer	0.0006	0.00104	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—lung cancer	0.0006	0.00104	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—lung cancer	0.000597	0.00103	CcSEcCtD
Cyproheptadine—Clozapine—CYP2A6—lung cancer	0.000589	0.133	CrCbGaD
Cyproheptadine—Diarrhoea—Paclitaxel—lung cancer	0.000588	0.00102	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—lung cancer	0.00058	0.001	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—lung cancer	0.000578	0.000999	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—lung cancer	0.000576	0.000995	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—lung cancer	0.000574	0.000992	CcSEcCtD
Cyproheptadine—Dizziness—Paclitaxel—lung cancer	0.000568	0.000982	CcSEcCtD
Cyproheptadine—Nausea—Cisplatin—lung cancer	0.000568	0.000982	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP2E1—lung cancer	0.000561	0.126	CrCbGaD
Cyproheptadine—Convulsion—Methotrexate—lung cancer	0.000557	0.000963	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—lung cancer	0.000557	0.000963	CcSEcCtD
Cyproheptadine—Rash—Etoposide—lung cancer	0.000553	0.000955	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—lung cancer	0.000552	0.000954	CcSEcCtD
Cyproheptadine—Headache—Etoposide—lung cancer	0.000549	0.000949	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—lung cancer	0.000547	0.000945	CcSEcCtD
Cyproheptadine—Vomiting—Paclitaxel—lung cancer	0.000546	0.000944	CcSEcCtD
Cyproheptadine—Rash—Paclitaxel—lung cancer	0.000542	0.000936	CcSEcCtD
Cyproheptadine—Dermatitis—Paclitaxel—lung cancer	0.000541	0.000936	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—lung cancer	0.000541	0.000935	CcSEcCtD
Cyproheptadine—Headache—Paclitaxel—lung cancer	0.000538	0.00093	CcSEcCtD
Cyproheptadine—HRH1—lymph node—lung cancer	0.00053	0.0111	CbGeAlD
Cyproheptadine—Confusional state—Methotrexate—lung cancer	0.000529	0.000915	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—lung cancer	0.000525	0.000907	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—lung cancer	0.000523	0.000903	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—lung cancer	0.000521	0.0009	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—lung cancer	0.000514	0.000888	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—lung cancer	0.000512	0.000885	CcSEcCtD
Cyproheptadine—Nausea—Paclitaxel—lung cancer	0.00051	0.000882	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—lung cancer	0.000507	0.000877	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—lung cancer	0.0005	0.000865	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—lung cancer	0.0005	0.000865	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—lung cancer	0.000499	0.000863	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—lung cancer	0.000499	0.000862	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—lung cancer	0.000498	0.000861	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—lung cancer	0.000492	0.000851	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—lung cancer	0.000491	0.000848	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—lung cancer	0.00049	0.000846	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—lung cancer	0.000483	0.000834	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—lung cancer	0.000482	0.000832	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—lung cancer	0.000475	0.000821	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—lung cancer	0.000471	0.000815	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—lung cancer	0.000467	0.000807	CcSEcCtD
Cyproheptadine—Vomiting—Docetaxel—lung cancer	0.000463	0.0008	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—lung cancer	0.000462	0.000799	CcSEcCtD
Cyproheptadine—Rash—Docetaxel—lung cancer	0.000459	0.000794	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—lung cancer	0.000459	0.000793	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—lung cancer	0.000458	0.000792	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—lung cancer	0.000456	0.000789	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—lung cancer	0.000456	0.000789	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—lung cancer	0.000455	0.000786	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—lung cancer	0.000453	0.000782	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—lung cancer	0.000447	0.000773	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—lung cancer	0.000445	0.000769	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—lung cancer	0.000444	0.000767	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—lung cancer	0.000439	0.00076	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—lung cancer	0.000433	0.000749	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—lung cancer	0.000433	0.000748	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—lung cancer	0.000433	0.000748	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—lung cancer	0.000425	0.000734	CcSEcCtD
Cyproheptadine—Clozapine—CYP2E1—lung cancer	0.000419	0.0943	CrCbGaD
Cyproheptadine—Urticaria—Methotrexate—lung cancer	0.000417	0.000721	CcSEcCtD
Cyproheptadine—Clozapine—CYP1A1—lung cancer	0.000413	0.093	CrCbGaD
Cyproheptadine—Insomnia—Doxorubicin—lung cancer	0.000411	0.000711	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—lung cancer	0.000408	0.000705	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—lung cancer	0.000404	0.000698	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—lung cancer	0.0004	0.000692	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—lung cancer	0.000395	0.000683	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—lung cancer	0.000392	0.000677	CcSEcCtD
Cyproheptadine—Amitriptyline—CYP2E1—lung cancer	0.000389	0.0877	CrCbGaD
Cyproheptadine—Constipation—Doxorubicin—lung cancer	0.000389	0.000672	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—lung cancer	0.000377	0.000651	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—lung cancer	0.000375	0.000647	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—lung cancer	0.000361	0.000624	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—lung cancer	0.000359	0.000621	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCB1—lung cancer	0.000357	0.0804	CrCbGaD
Cyproheptadine—Dizziness—Methotrexate—lung cancer	0.000347	0.0006	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—lung cancer	0.000334	0.000577	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—lung cancer	0.000331	0.000572	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—lung cancer	0.000331	0.000572	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—lung cancer	0.000329	0.000568	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—lung cancer	0.000326	0.000564	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—lung cancer	0.000312	0.000539	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—lung cancer	0.000311	0.000538	CcSEcCtD
Cyproheptadine—Nortriptyline—ALB—lung cancer	0.000308	0.0694	CrCbGaD
Cyproheptadine—Dizziness—Doxorubicin—lung cancer	0.000301	0.00052	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—lung cancer	0.000289	0.0005	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—lung cancer	0.000287	0.000495	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—lung cancer	0.000286	0.000495	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—lung cancer	0.000285	0.000492	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—lung cancer	0.00027	0.000467	CcSEcCtD
Cyproheptadine—Clozapine—ABCB1—lung cancer	0.000219	0.0494	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—lung cancer	0.000214	0.0482	CrCbGaD
Cyproheptadine—Amitriptyline—ABCB1—lung cancer	0.000204	0.046	CrCbGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	2.01e-05	5.43e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MDM2—lung cancer	2e-05	5.41e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RAF1—lung cancer	1.99e-05	5.39e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—lung cancer	1.98e-05	5.37e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—lung cancer	1.98e-05	5.37e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—lung cancer	1.98e-05	5.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	1.97e-05	5.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—lung cancer	1.97e-05	5.34e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—lung cancer	1.97e-05	5.33e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.97e-05	5.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—lung cancer	1.97e-05	5.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MDM2—lung cancer	1.97e-05	5.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.96e-05	5.31e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MDM2—lung cancer	1.96e-05	5.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—lung cancer	1.96e-05	5.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—lung cancer	1.96e-05	5.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RAF1—lung cancer	1.96e-05	5.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.96e-05	5.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MDM2—lung cancer	1.96e-05	5.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RAF1—lung cancer	1.95e-05	5.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MDM2—lung cancer	1.95e-05	5.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RAF1—lung cancer	1.95e-05	5.28e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	5.26e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—lung cancer	1.94e-05	5.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RAF1—lung cancer	1.94e-05	5.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—lung cancer	1.94e-05	5.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.94e-05	5.25e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.93e-05	5.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.93e-05	5.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.93e-05	5.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—lung cancer	1.92e-05	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RAF1—lung cancer	1.92e-05	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.92e-05	5.2e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—lung cancer	1.92e-05	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.92e-05	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—lung cancer	1.91e-05	5.18e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—lung cancer	1.91e-05	5.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—lung cancer	1.91e-05	5.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—lung cancer	1.91e-05	5.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—lung cancer	1.91e-05	5.17e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.91e-05	5.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1A—lung cancer	1.91e-05	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—lung cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—lung cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—lung cancer	1.9e-05	5.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.9e-05	5.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.88e-05	5.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—lung cancer	1.88e-05	5.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—EP300—lung cancer	1.87e-05	5.06e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—lung cancer	1.87e-05	5.06e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.87e-05	5.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—lung cancer	1.86e-05	5.03e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—lung cancer	1.86e-05	5.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—lung cancer	1.84e-05	4.98e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.83e-05	4.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.83e-05	4.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—lung cancer	1.83e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EP300—lung cancer	1.82e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—lung cancer	1.82e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—lung cancer	1.82e-05	4.93e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.82e-05	4.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.82e-05	4.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EP300—lung cancer	1.81e-05	4.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—lung cancer	1.81e-05	4.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—lung cancer	1.81e-05	4.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.8e-05	4.89e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	4.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.79e-05	4.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—lung cancer	1.79e-05	4.84e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—lung cancer	1.79e-05	4.83e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—lung cancer	1.78e-05	4.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—lung cancer	1.78e-05	4.81e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—lung cancer	1.77e-05	4.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.77e-05	4.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.77e-05	4.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—lung cancer	1.76e-05	4.78e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—lung cancer	1.76e-05	4.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—lung cancer	1.76e-05	4.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—lung cancer	1.76e-05	4.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—lung cancer	1.76e-05	4.76e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—lung cancer	1.76e-05	4.75e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—lung cancer	1.75e-05	4.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—lung cancer	1.75e-05	4.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—lung cancer	1.75e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—lung cancer	1.75e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—lung cancer	1.74e-05	4.72e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—lung cancer	1.74e-05	4.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.74e-05	4.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—lung cancer	1.74e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—lung cancer	1.74e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—lung cancer	1.74e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—lung cancer	1.74e-05	4.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—lung cancer	1.73e-05	4.69e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.73e-05	4.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.73e-05	4.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—lung cancer	1.72e-05	4.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—lung cancer	1.72e-05	4.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.72e-05	4.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—lung cancer	1.71e-05	4.64e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—lung cancer	1.71e-05	4.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—lung cancer	1.71e-05	4.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—lung cancer	1.71e-05	4.63e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NRAS—lung cancer	1.71e-05	4.62e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—lung cancer	1.7e-05	4.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—lung cancer	1.7e-05	4.61e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—lung cancer	1.7e-05	4.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—lung cancer	1.7e-05	4.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NRAS—lung cancer	1.7e-05	4.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—lung cancer	1.7e-05	4.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—lung cancer	1.69e-05	4.59e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—lung cancer	1.69e-05	4.57e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—lung cancer	1.69e-05	4.57e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	4.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.68e-05	4.55e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—lung cancer	1.68e-05	4.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—lung cancer	1.68e-05	4.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—lung cancer	1.66e-05	4.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—lung cancer	1.66e-05	4.5e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—lung cancer	1.66e-05	4.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.66e-05	4.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—lung cancer	1.65e-05	4.48e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.65e-05	4.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—lung cancer	1.65e-05	4.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—lung cancer	1.65e-05	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—lung cancer	1.65e-05	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.65e-05	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—lung cancer	1.64e-05	4.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.64e-05	4.45e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—lung cancer	1.64e-05	4.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—lung cancer	1.64e-05	4.44e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.63e-05	4.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.63e-05	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.63e-05	4.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—lung cancer	1.63e-05	4.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.62e-05	4.39e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—lung cancer	1.61e-05	4.37e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.61e-05	4.37e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—lung cancer	1.61e-05	4.36e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.61e-05	4.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.6e-05	4.34e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EP300—lung cancer	1.6e-05	4.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.6e-05	4.33e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—lung cancer	1.59e-05	4.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.58e-05	4.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—lung cancer	1.58e-05	4.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EP300—lung cancer	1.58e-05	4.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EP300—lung cancer	1.57e-05	4.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EP300—lung cancer	1.57e-05	4.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EP300—lung cancer	1.56e-05	4.23e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—lung cancer	1.56e-05	4.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—lung cancer	1.55e-05	4.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EP300—lung cancer	1.55e-05	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—lung cancer	1.55e-05	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—lung cancer	1.54e-05	4.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—lung cancer	1.53e-05	4.15e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—lung cancer	1.53e-05	4.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—lung cancer	1.52e-05	4.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—lung cancer	1.52e-05	4.11e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—lung cancer	1.52e-05	4.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—lung cancer	1.5e-05	4.07e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—lung cancer	1.5e-05	4.07e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NRAS—lung cancer	1.5e-05	4.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.49e-05	4.04e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.49e-05	4.03e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—lung cancer	1.49e-05	4.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.48e-05	4.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.48e-05	4.01e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—lung cancer	1.48e-05	4e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—lung cancer	1.47e-05	3.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NRAS—lung cancer	1.47e-05	3.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—lung cancer	1.47e-05	3.99e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NRAS—lung cancer	1.47e-05	3.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.47e-05	3.98e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—lung cancer	1.47e-05	3.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.47e-05	3.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.47e-05	3.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—lung cancer	1.47e-05	3.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NRAS—lung cancer	1.46e-05	3.96e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—lung cancer	1.46e-05	3.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.45e-05	3.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.45e-05	3.92e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—lung cancer	1.44e-05	3.89e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.41e-05	3.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.41e-05	3.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.4e-05	3.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.4e-05	3.79e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—lung cancer	1.4e-05	3.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.39e-05	3.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—lung cancer	1.38e-05	3.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—lung cancer	1.37e-05	3.72e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—lung cancer	1.37e-05	3.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—lung cancer	1.37e-05	3.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—lung cancer	1.37e-05	3.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—lung cancer	1.36e-05	3.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—lung cancer	1.36e-05	3.68e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.35e-05	3.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—lung cancer	1.35e-05	3.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.34e-05	3.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.34e-05	3.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—lung cancer	1.34e-05	3.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.34e-05	3.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.33e-05	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.32e-05	3.57e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—lung cancer	1.31e-05	3.53e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—lung cancer	1.3e-05	3.52e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—lung cancer	1.29e-05	3.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.27e-05	3.44e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—lung cancer	1.27e-05	3.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.26e-05	3.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.26e-05	3.41e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.25e-05	3.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.25e-05	3.37e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.24e-05	3.36e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—lung cancer	1.19e-05	3.24e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—lung cancer	1.19e-05	3.22e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	3.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.17e-05	3.16e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.16e-05	3.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.16e-05	3.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.16e-05	3.13e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—lung cancer	1.15e-05	3.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.14e-05	3.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—lung cancer	1.13e-05	3.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—lung cancer	1.13e-05	3.05e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—lung cancer	1.13e-05	3.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—lung cancer	1.12e-05	3.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—lung cancer	1.12e-05	3.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—lung cancer	1.11e-05	3e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.1e-05	2.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.1e-05	2.97e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—lung cancer	1.1e-05	2.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.08e-05	2.92e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—lung cancer	1.08e-05	2.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—lung cancer	1.07e-05	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—lung cancer	1.07e-05	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—lung cancer	1.06e-05	2.87e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—lung cancer	1.05e-05	2.84e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—lung cancer	1.03e-05	2.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—lung cancer	1.03e-05	2.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—lung cancer	1.03e-05	2.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—lung cancer	1.02e-05	2.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—lung cancer	1.01e-05	2.74e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—lung cancer	9.68e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—lung cancer	9.52e-06	2.58e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—lung cancer	9.5e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—lung cancer	9.47e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—lung cancer	9.44e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—lung cancer	9.35e-06	2.53e-05	CbGpPWpGaD
